News
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized ...
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the biotech stocks to buy according to Wall Street analysts.
Dealmaking is in style again under President Donald Trump. Potential takeover targets include C3.ai, Viking Therapeutics, and ...
I've been writing about the LG C3 OLED TV since its release in 2023, and it has consistently been a best-seller, thanks to ...
Huntington Ingalls Industries Inc (HII) reports a 3.5% revenue increase and significant contract awards, while navigating ...
Investing.com -- Teleperformance (EPA: TEPRF) shares plunged more than 16% on Friday after the company cut its full-year revenue outlook, reported weaker-than-expected margins and missed earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results